Jiří Hák
Impact in
-
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
-
- Acute Lymphoblastic Leukemia research
Papers in
-
- Acute Lymphoblastic Leukemia research 7
-
- RNA modifications and cancer 2
- Cancer-related gene regulation 2
- Retinoids in leukemia and cellular processes 2
- Co-authors
- Radek Čmejla (3 shared papers)Jana Čmejlová (3 shared papers)Dagmar Pospı́šilová (4 shared papers)Tomáš Adam (1 shared paper)Jan Starý (5 shared papers)Jan Trka (2 shared papers)Y. Jabali (3 shared papers)Ondřej Hrušák (2 shared papers)
In The Last Decade
Jiří Hák
13 papers receiving 161 citations
Peers
Comparison fields: 5 of 39
- Hematology 63
- Public Health, Environmental and Occupational Health 56
- Genetics 14
- Molecular Biology 90
- Pediatrics, Perinatology and Child Health 18
Countries citing papers authored by Jiří Hák
This map shows the geographic impact of Jiří Hák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiří Hák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiří Hák more than expected).
Fields of papers citing papers by Jiří Hák
This network shows the impact of papers produced by Jiří Hák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiří Hák. The network helps show where Jiří Hák may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiří Hák, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 59 | |
| 2 | 2010 | 42 | |
| 3 | 2012 | 21 | |
| 4 | 2011 | 14 | |
| 5 | 1979 | 10 | |
| 6 | 2012 | 6 | |
| 7 | 1997 | 3 | |
| 8 | 2012 | 2 | |
| 9 | 2021 | 2 | |
| 10 | 2011 | 2 | |
| 11 | 2000 | 1 | |
| 12 | 2006 | 1 | |
| 13 | [Isolated leukemic infiltration of the iris]. | 1993 | 1 |
| 14 | Tumory močového ústrojí vzácná příčina hematurie u dětí | 2006 | 0 |
About Jiří Hák
Jiří Hák is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology, Pediatrics, Perinatology and Child Health, Hematology and Surgery, having authored 14 papers that have together received 164 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (7 papers), Acute Myeloid Leukemia Research (5 papers), Childhood Cancer Survivors' Quality of Life (4 papers), RNA modifications and cancer (2 papers), Cancer-related gene regulation (2 papers), Retinoids in leukemia and cellular processes (2 papers), Lymphoma Diagnosis and Treatment (1 paper) and Cholinesterase and Neurodegenerative Diseases (1 paper). The work is most often cited by research in Hematology (63 citations), Public Health, Environmental and Occupational Health (56 citations), Genetics (14 citations), Molecular Biology (90 citations) and Pediatrics, Perinatology and Child Health (18 citations). Jiří Hák has collaborated with scholars based in Czechia, Slovakia and Germany. Frequent co-authors include Radek Čmejla, Jana Čmejlová, Dagmar Pospı́šilová, Tomáš Adam, Jan Starý, Jan Trka, Y. Jabali, Ondřej Hrušák, Jaroslav Štěrba and Dagmar Procházková. Their work appears in journals such as Haematologica, Cancer Epidemiology, Leukemia Research, Blood Cells Molecules and Diseases and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.